Product Description
Introduction to India P-force (Blue P):
P-force and its active ingredient Sildenafil (English: Sildenafil) is a medication for male erectile dysfunction that was accidentally discovered during research on cardiovascular disease treatments. Currently, Pfizer's patent on Sildenafil has expired, allowing other manufacturers to legally produce the same drug. Among various countries worldwide, the dual-effect Viagra developed by India's Sunrise Remedies is the most well-known, commonly referred to as India P-force, also known as Blue P!
P-force (Blue P) Effects and Benefits:
P-force ingredients: Sildenafil 100mg + Dapoxetine 100mg, a dual-action formula combining erection support and endurance extension, making it one of the most potent products available. Since the degree of premature ejaculation varies among men—ranging from mild, moderate, to severe—the required dosage differs accordingly. To facilitate patient use, the company offers different dosage options, allowing you to experience the most suitable, comfortable, and intensely pleasurable sexual experience! For many men who suffer from both erectile dysfunction, insufficient firmness, and premature ejaculation, and to avoid the unnecessary harm of taking two separate medications simultaneously, researchers developed the perfect solution: P-force Extra Super (Sildenafil 100mg + Dapoxetine 100mg), which effectively enhances erection firmness and prolongs sexual duration. The recommended interval between doses is 24 hours. Due to its potent effects and longer retention time in the body, it should not be taken more than once within a 24-hour period.
【Precautions】:
1. Use with caution in patients with hypertension or heart disease.
2. Not for use by minors under 18 years of age.
3. This product is intended solely for use between married couples or intimate partners; do not use for any other purposes.
4. Do not take other medications within 12 hours before or after taking this product.
5. For individuals aged 65 and above, those with liver impairment, severe kidney damage, or those concurrently taking strong cytochrome P450 3A4 inhibitors (such as ketoconazole, itraconazole) or erythromycin, the effectiveness may be reduced.




